CARDINAL HEALTH INC (CAH) Stock
CAH has an Alpha Score of 50 out of 100 (weak), computed on Oct 29, 2026 from 3 of 4 sub-scores. 12 members of Congress disclosed 24 trades in CAH since 2014: 17 purchases and 7 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 6 of the hedge funds AlphaScala tracks reported CAH in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $130.72M. Company insiders reported 0 open-market buys and 31 sales on SEC Form 4 in the 90 days to Nov 2, 2026. Its trailing P/E ratio is 34.7 and its net margin 0.7% (key statistics as of Oct 22, 2026).
What is CAH's Alpha Score?
How it works →Alpha Score of 50 reflects moderate overall profile with strong momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 29, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded CARDINAL HEALTH INC (CAH)?
Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Feb 27, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2025-10-24 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2025-05-14 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2025-05-05 | purchase | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-04-08 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2025-03-17 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2025-01-21 | purchase | $1k – $15k |
| Marjorie Taylor Greene R-GA · House | 2024-09-20 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 1, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded CAH, with filing lags →Which hedge funds own CAH?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 550K | $130.72M | +51% |
| Renaissance Technologies Jim Simons (founder) | 550K | $130.68M | +60% |
| Millennium Management Israel Englander | 255K | $60.51M | -63% |
| Marshall Wace | 235K | $55.90M | -56% |
| Citadel Ken Griffin | 194K | $46.07M | -92% |
| Bridgewater Associates Ray Dalio | 132K | $31.38M | +15% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are CARDINAL HEALTH INC insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 6.2K | $1.4M |
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 3.5K | $810K |
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 5.7K | $1.3M |
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 6.7K | $1.6M |
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 16.2K | $3.8M |
| Aug 19, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 6.2K | $1.5M |
| Aug 19, 26 | Scherer Mary C. | Chief Accounting Officer | SELL | 100 | $24K |
| Aug 19, 26 | Scherer Mary C. | Chief Accounting Officer | SELL | 2.2K | $523K |
| Aug 18, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 21.4K | $5.0M |
| Aug 18, 26 | Hollar Jason M. | Chief Executive Officer | SELL | 29.9K | $7.0M |
SEC Form 4 filings as of Nov 2, 2026
See cluster-buy signals across all tickers →What are CAH's key statistics?
Key statistics as of Oct 22, 2026
How does CAH's valuation compare with the Healthcare sector?
| Metric | CAH | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 34.7 | 27.2 | 99 |
| Net margin | 0.67% | 4.85% | 143 |
| Return on equity | 37.17% | 6.68% | 162 |
| Dividend yield (payers) | 1.88% | 1.62% | 50 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 3, 2026). P/E excludes loss-making companies.
CAH price chart
Powered by TradingViewWhat does CARDINAL HEALTH INC do?
Cardinal Health Inc. is a leading healthcare services and products company that provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It specializes in distributing branded, generic, specialty pharmaceutical, over-the-counter healthcare, and consumer products through its Pharmaceutical and Specialty Solutions segment. The Medical segment, including Global Medical Products and Distribution, manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products, along with equipment to healthcare facilities across North America, Europe, and Asia. Additional operations encompass at-Home Solutions, Nuclear and Precision Health Solutions, and OptiFreight Logistics, enhancing supply chain efficiency and cost-effectiveness. As one of the three major U.S. pharmaceutical wholesalers, Cardinal Health Inc. holds significant market presence, sourcing and delivering products to retail chains, independent pharmacies, mail-order services, hospital networks, and providers. Founded in 1979 and headquartered in Dublin, Ohio, it plays a vital role in the medical distribution industry.